Introduction

9
Recent advances in the scalability of single cell RNA-sequencing (scRNA-seq) offer a 4 0 new window into development, the cellular diversity of complex tissues, cellular response to 4 1 stimuli, and human disease. Conventional methods for cell-type discovery find clusters of cells 4 2 with similar expression profiles, followed by statistical analysis to identify subpopulation-4 3 specific markers [2] [3] [4] [5] . Studies of cell fate specification have benefitted from innovative methods 4 4
for inferring pseudo-temporal orderings of cells, allowing identification of genes that vary along 4 5 a trajectory [6] [7] [8] . By design, these approaches discover expression programs associated with 4 6
either discrete subpopulations or ordered phenotypes like differentiation status. However, in 4 7
addition to cell type and developmental maturity, a cell's transcriptional state may include 4 8
physiological processes like metabolism, growth, stress, and cell cycle; widespread 4 normalization and explicitly model variable sparsity across both cells and genes. We compare 7 0 scHPF to popular normalization and dimensionality reduction methods as well as an algorithm 7 1 explicitly designed for scRNA-seq. scHPF has better predictive performance than these methods 7 2
and more closely captures expression variability in datasets generated by multiple experimental 7 3
technologies. Finally, we apply scHPF to single-cell expression profiles obtained from the core 7 4
and invasive edge of a high-grade glioma. scHPF identifies both expected and novel features of 7 5
tumor cells at single-cell resolution and uncovers a prognostic expression signature associated 7 6
with poor survival in glioblastoma. 7 7 7 8
Results
9
Single-cell Hierarchical Poisson Factorization 8 0 scHPF uses Hierarchical Poisson Factorization [1] for de novo identification of gene 8 1 expression programs. In scHPF, each cell or gene has a limited "budget" which it distributes 8 2 across the latent factors (Fig. 1) . In cells, this budget is constrained by transcriptional output and 8 3 experimental sampling. Symmetrically, a gene's budget reflects its sparsity due to overall 8 4 expression level, sampling, and variable detection. The interaction of a given cell and gene's 8 5
budgeted loadings over factors determines the number of molecules of the gene detected in the 8 6
cell. 8 7
More formally, scHPF is a hierarchical Bayesian model of the generative process for an 8 8 M x N discrete expression matrix, where M is the number of genes and N is the number of cells 8 9
( Fig. S1a) . scHPF assumes that each gene ݃ and cell ܿ is associated with an inverse-budget ߟ 9 0 and ߦ that probabilistically determines the observed transcriptional output for that cell or gene. 9 1
Since both ߟ and ߦ are positive-valued, scHPF places Gamma distributions over those latent 9 2
variables. The hyperparameters of these Gamma distributions are set empirically (Methods, Fig.  9 3 S1b). For each factor negative binomial distribution; therefore, scHPF implicitly contains a negative binomial 1 0 0 distribution in its generative process. Given a gene expression matrix, scHPF approximates the 1 0 1 posterior distribution over the inverse budgets and latent factors given the data using Coordinate 1 0 2
Ascent Variational Inference [18, 19] Benchmarking against alternative methods 1 0 9
We compared scHPF's predictive performance to that of PCA, NMF, Factor Analysis 1 1 0 (FA), and Zero Inflated Factor Analysis (ZIFA) [14] , a method developed specifically for 1 1 1 scRNA-seq. These methods have been used for de novo expression program discovery without a 1 1 2 pre-defined structure across cells [9] [10] [11] [12] 14] . We assessed each method across three datasets in 1 1 3 different biological systems and obtained with different experimental platforms ( For each dataset, we tested conventional methods with three different normalizations: 1 2 2 log-transformed molecular counts, counts per median (rate-normalization), and log-transformed 1 2 3 counts per median (log-rate-normalization). ZIFA was only evaluated using log-transformed 1 2 4 normalizations as recommended by its authors. Across all datasets and normalizations, scHPF 1 2 5
had the best predictive performance on a held-out test set ( Fig. 2a) . scHPF's superior 1 2 6
performance was robust across a range of values for ‫ܭ‬ , the number of factors ( Fig. S2) . 1 2 7
In bulk RNA-seq, modeling over-dispersed gene expression data has proven essential to 1 2 8 downstream analysis [17] . In scRNA-seq, expression data are over-dispersed both across genes 1 2 9
in individual cells and for individual genes across cells. We evaluated how well different 1 3 0 factorization methods captured single cell expression variability using a posterior predictive 1 3 1 check (PPC). PPCs provide insight into a generative model's goodness-of-fit by comparing the 1 3 2 observed dataset to simulated data generated from the model. More formally, PPCs sample 1 3 3 simulated replicate datasets X rep from a generative model's posterior predictive distribution and 1 3 4 use a modeler-defined test statistic to evaluate discrepancies between X rep and the true data, X obs 1 3 5
[24]. For each dataset, normalization, and generative factorization method (scHPF, PCA, FA 1 3 6
and ZIFA), we sampled ten replicate expression vectors per cell. After converting samples from 1 3 7 models on normalized data back to molecular counts (Methods), we computed the coefficient of 1 3 8 variation (CV) for all genes in each cell and each gene across all cells. Finally, we averaged each 1 3 9
cell and gene's CVs across the ten replicate simulations. In all three datasets, scHPF more 1 4 0 closely matched the observed data's variability than other methods ( Fig. 2b, Fig. S3 ). We 1 4 1 noticed that many samples from PCA and FA had physically impossible negative values. When 1 4 2 we corrected these values by clipping them to zero, PCA and FA's estimates of variability across 1 4 3 cells collapsed toward zero (Fig. 2c) . This collapse suggests that PCA and FA's ability to model 1 4 4 over-dispersion in scRNA-seq data depends on placing probability mass on negative gene 1 4 5 expression levels. 1 4 6 1 4 7
Application to Spatially Sampled scRNA-seq from High-Grade Glioma 1 4 8
As a demonstration, we applied scHPF to 6,109 single cell expression profiles from the 1 4 9 core and invasive edge of a high-grade glioma. High-grade gliomas (HGGs), the most common 1 5 0
and lethal brain malignancies in adults [25] , are highly heterogeneous tumors with complex 1 5 1 microenvironments. In HGG, malignant cells invade the surrounding brain tissue, forming 1 5 2 diffusely infiltrated margins that are impossible to fully remove surgically [26] . Although 1 5 3 malignant cells in margins seed tumor recurrence and are the targets of post-operative therapy, 1 5 4
most molecular characterization has focused on HGG cores. To investigate the transcriptional 1 5 5 differences between cells in glioma's core and margins, we used an MRI-guided procurement 1 5 6 technique [26] and scRNA-seq to profile 3,109 cells from an HGG core and 3,000 cells from its 1 5 7
margin. While recent efforts are beginning to shed light on the differential expression between 1 5 8 glioma's core and margins [26, 27] , few studies involve this kind of spatial sampling. 1 5 9
Glioma cells typically resemble glia at the level of gene expression, and our prior work 1 of complex cellular populations, and much can be learned from projecting single-cell expression 2 4 2 profiles onto these structures. scHFP effectively models the nuanced features of scRNA-seq data 2 4 3 while identifying highly variable gene signatures, unconstrained by predefined structures such as 2 4 4 clusters or trajectories. We anticipate that scHFP will be a complementary tool for dissecting the 2 4 5 transcriptional underpinnings of cellular identity and state. Single-cell Hierarchical Poisson Factorization 2 5 0
The generative process for single-cell Hierarchical Poisson Factorization, illustrated in Figure 2 5 1 S1a, is: 
This adjusts factor loadings for the learned transcriptional output of their corresponding cell or 2 6 8
gene. Finally, we rank the genes in each factor by their scores to identify de novo patterns of 2 6 9 coordinated gene expression (e.g. Fig S6a) preserve the empirical variance to mean ratio of the total molecules per cell or gene in the 2 7 6
Gamma distributions from which ߦ and ߟ are drawn. Specifically, we set 2 7 7
To preserve sparsity, we fix ܽ and ܿ to 0.3 and
ܽ '
and ܿ ' to 1. In this scheme, we find the 2 8 1 algorithm largely insensitive to small changes in the hyperparameters. We initialize the 2 8 2 variational distributions for
to their priors times a random multiplier between 0.5 and 2 8 3 1.5.
8 4
Selection of number of factors 2 8 5
In actually usage, such as the for the high-grade glioma demonstration in this paper, we select the 2 8 6 number of factors ‫ܭ‬ such that (1) the model's log likelihood has converged ( Fig. S9a) and (2) 2 8 7 each well-defined cell-type in the dataset is most strongly associated with at least one factor with 2 8 8
which no other cell-type is most strongly associated ( Fig. S9b-d) . For benchmarking 2 8 9 experiments, to avoid biasing results toward any one method, we set the number for factors to the 2 9 0 smallest multiple of five greater than the number of clusters for the PBMC and Matcovitch et al.
datasets, and to five for TS543 (Table S1 ). However, predictive performance was robust to a 2 9 2
range of values for ‫ܭ‬ ( Fig. S2 ). 2 9 3 2 9 4
Benchmarking 2 9 5
Log-normalization was applied by adding 1 to molecular counts and then taking the logarithm. 2 9 6
Counts per median (rate-normalization) were calculated by normalizing the molecular counts in 2 9 7 each cell to sum to 1 and then multiplying all values by the median number of molecules per cell. 2 9 8
For log-rate-normalization, we performed the log-normalization procedure described above on 2 9 9 rate-normalized data. PCA, NMF, and FA were applied using the scikit-learn python package, 3 0 0 with default parameters [40] . To test ZIFA, we used its authors' block_ZIFA implementation 3 0 1
with parameter p0_thresh=1 and otherwise default settings. Prior to training, we randomly 3 0 2 selected 4% of nonzero expression values to use as a held-out test set and 2% as a validation set. 3 0 3
The remaining data were used as a training set. By holding out only a small portion of data, we 3 0 4 aimed to minimally impact datasets' native sparsity structure. As these test and validation sets 3 0 5
were small compared to the training set, we evaluated methods' predictive performance on at 3 0 6
least three randomly chosen partitions of the data into training, validation and test sets. We ran 3 0 7 each method-normalization pair with ten random initializations on each training set and selected 3 0 8
the run with the lowest mean absolute error on the corresponding validation set. Due to ZIFA's 3 0 9
long runtime (~23 hours per initialization on TS543), we only ran it with five initializations per 3 1 0 training set and for only one value of ‫ܭ‬ ( Fig. S2) .
We generated posterior predictive samples from scHPF by sampling latent 3 1 2 representations ߠ and ߚ from the variational posterior and taking the inner product. For PCA, 3 1 3
FA, and ZIFA, we sampled latent representations and expression values according to their 3 1 4
underlying generative models [41] . For each method, normalization, and dataset, we sampled 3 1 5
ten M x N datasets. Samples from models on normalized data were inverse transformed back to 3 1 6 molecular counts before calculating column and row coefficients of variation. For example, 3 1 7
samples from PCA on log-normalized data were added to -1 and then exponentiated before 3 1 8
calculating coefficients of variation. Each gene and cell's coefficient of variation was averaged 3 1 9
across ten replicate posterior predictive simulations. The Kolomgorov-Smirniov test statistic was 3 2 0 calculated using the python package scipy. 3 2 1 3 2 2
Published scRNA-seq datasets 3 2 3
The filtered PBMC dataset, using Chromium v2 chemistry, was downloaded from 10x Genomics 3 2 4
( https://support.10xgenomics.com/single-cell-gene-expression/datasets/2.1.0/pbmc4k ). 3 2 5
Molecular counts for Matcovitch et al. were retrieved from GEO ascension GSE7918. 3 2 6 3 2 7
Preparation of TS543 glioma neurospheres 3 2 8
TS543 cells were plated at density 1 x 104 viable cells/cm 2 and grown as neurospheres with 3 2 9
NeuroCult™ NS-A Basal Medium supplemented with NeuroCult™ NS-A Proliferation 3 3 0
Supplement, 20ng/ml EGF, 10ng/ml bFGF, and 0.0002% Heparin (Stem Cell Technologies). 3 3 1
When diameters of neurospheres reached to approximately 100μm, neurospheres were 3 3 2 dissociated to single cells with mechanical force by pipetting 30-50 times. Radiographically-guided biopsies of high-grade glioma 3 3 5
Human glioma surgical specimens were procured from de-identified patients through a protocol 3 3 6
approved by the Columbia Institutional Review Board (IRB). Radiographically-guided biopsies 3 3 7
were obtained as described in [26] . Briefly, the patient studied here presented with FLAIR hyper-3 3 8
intense, non-contrast-enhancing tissue along the surgical trajectory based on MRI between the 3 3 9
craniotomy site and gadolinium contrast-enhancing border of the lesion. This region was 3 4 0 biopsied and comprised the tumor margin specimen described above. A region of the contrast-3 4 1 enhancing core of the lesion was also biopsied and comprised the tumor core specimen. Whole-genome sequencing 3 4 4
Low-pass whole genome sequencing (WGS) was conducted as described in [28] . Briefly, we 3 4 5
homogenized tissue with a Dounce and extracted DNA and RNA with a ZR-Duet Kit (Zymo) 3 4 6 according to the manufacturer's instructions. For the normal control, DNA and RNA were 3 4 7 extracted using the same kit from peripheral blood mononuclear cells. WGS libraries were 3 4 8
constructed by in vitro transposition using the Illumina Nextera XT kit and sequenced on an 3 4 9
Illumina NextSeq 500 with 2x75 base paired-end reads to a depth of ~1x. Reads were aligned to 3 5 0 the hg19 build of the human genome using bwa-mem and the coverage for each chromosome 3 5 1
was quantified using bedtools after collapsing PCR duplicates with samtools. To generate the 3 5 2 bulk WGS heatmap in Fig. S5e , we took the divided the normalized coverage of each 3 5 3 chromosome in the tumor sample by that of the normal sample, normalized the resulting ratio by 3 5 4
the median ratio across all chromosomes, and multiplied by two to estimate average copy 3 5 5
number of each chromosome in the tumor sample. 3 5 6 3 5 7
scRNA-seq data preprocessing 3 5 8
Reads for TS543 and HGG samples were processed into molecular count matrices as described 3 5 9
in Yuan et al. [28] . For all benchmarking and scHPF analyses, we only considered protein-3 6 0
coding genes that were expressed in at least 0.1% of cells in the dataset, rounded to the next 3 6 1 largest multiple of 5 (Table S1 ). 3 6 2 3 6 3
Identification of malignant glioma cells 3 6 4
We identified malignantly transformed cells by two orthogonal methods. First, we clustered 3 6 5
cells' scRNA-seq profiles (see Clustering and visualization) and defined putative malignant cells 3 6 6
using the genes most specific to each cluster (Figure S4, S5a) . Next, we performed PCA of 3 6 7
cells' whole-chromosome expression and found that the first principal component, which we call 3 6 8
the malignancy score, separated putatively transformed cells from non-malignant cells ( Fig. S5b-3  6  9 d). For further validation, we computed putative glioma cells' average chromosomal expression 3 7 0
profiles relative to putative non-malignant cells and found that they were in good agreement with 3 7 1 aneuploidies identified by low-coverage whole genome sequencing of bulk tissue from the tumor 3 7 2 core ( Fig. S5e) . Clustering and visualization 3 7 5
Clustering, visualization and identification of cluster-specific genes was performed similarly to 3 7 6
Yuan et al. [28] , with an updated method for selecting genes detected in fewer cells than 3 7 7 expected given their apparent expression level (likely markers of cellular subpopulations). 3 7 8
Briefly, for variable gene selection only, we normalized the molecular counts for each cell to 3 7 9
sum to 1. Genes were then ordered by their normalized expression values. For each gene . 3 8 5
We selected marker genes with dropout scores that are either greater than 0.15 or at least six 3 8 6 standard deviations above the mean, inclusively. 3 8 7
To cluster and visualize the data, we computed a cell by cell Spearman's correlation 3 8 8 matrix using the marker genes identified above. Using this matrix, we constructed a k-nearest 3 8 9
neighbors graph (k=20), which we then used as input to Louvain clustering with Phenograph [4]. 3 9 0
After clustering, we identified genes most specific to each cluster using a binomial test [5]. The 3 9 1 same similarity matrix, transformed into a distance matrix by subtracting its values from 1, was 3 9 2
used as input to tSNE for visualization. 3 9 3 3 9 4
Regional biases 3 9 5
p-values for both factors and top scoring genes in each factor were calculated using the Mann-3 9 6
Whitney U-test and Bonferroni corrected for the total number of factors. 3 9 7 3 9 8
Survival analysis 3 9 9
TCGA data for glioblastoma was downloaded from GDAC Firehose. Normalized expression 4 0 0 values were log 2 (RSEM+ 1) transformed and each factor's expression program was defined as its 4 0 1 25 highest scoring genes. We then calculated each program's mean relative expression for each 4 0 2 donor, and z-scored these values across donors. For each program, donors with z-scores greater 4 0 3 than 1.5 were considered enriched, and all others were defined as not enriched. Patients with z-4 0 4
scores less than -1.5 were considered depleted. Kaplan-Meier curves and log-rank test p-values 4 0 5
were generated with the Lifelines v0.11. Scores for myeloid factor 1 (y-axis) vs. myeloid factor 2 (x-axis) for cells in the myeloid Louvain to sum to 100. Biases are driven by the top genes in each factor (Fig. S7d-f 
